Jacob Traff

Blue Wolf on the acquisition of Synerlab

Apax Partners on various transactions, including the:

• proposed acquisition of Zellis from Bain Capital and subsequent acquisition of Benify from Vitruvian (together with a related minority investment by Vitruvian)
• sale by its portfolio company Healthium of its Clinisupplies business to KKR and subsequent sale of Healthium to another KKR fund
• simultaneous acquisitions of OCS and Finwave from, respectively, Charme Capital Partners and Lutech
• proposed £220 million public-to-private of Kin and Carta plc
• NOK 3.8 billion public-to-private of EcoOnline and subsequent acquisitions of the software division of Alcumus (together with a related minority investment by Inflexion) and Ecometrica
• acquisition of Lutech from One Equity Partners
• acquisition of PIB Group from Carlyle
• $3.4 billion public-to-private (together with Warburg Pincus, CPPIB and OTPP) of Inmarsat and subsequent $7.3 billion combination of Inmarsat with Viasat

Bain Capital Private Equity on various transactions, including the:

• acquisition of Eleda from Altor
• proposed €1.1 billion public-to-private (together with its consortium partners) of Caverion Corporation
• €3.0 billion acquisition (together with BC Partners) of Fedrigoni
• investment in CitiusTech alongside Baring Private Equity Asia
• €1.7 billion acquisition (together with its consortium partners) of ITP Aero from Rolls-Royce
• €2.1 billion public-to-private (together its consortium partners) of Ahlstrom-Munksjö Oyj (now Ahlstrom)
• equity arrangements in connection with the acquisition (together with NB Renaissance) of Engineering Group
• proposed €3.4 billion public-to-private (together with Carlyle) for OSRAM
• acquisition of Maesa
• acquisition of DSM Sinochem Pharmaceuticals (now Centrient) from Royal DSM and Sinochem
• sale of its stake in Securitas Direct / Verisure to Hellman & Friedman
• €1.35 billion sale (together with Altor) of EWOS to Cargill

Cinven and Bain Capital Private Equity on the:

• CHF 4.2 billion acquisition of Lonza’s Specialty Ingredients business (now Arxada) and subsequent acquisitions of Troy Corporation and Enviro Tech
• €5.3 billion public-to-private of STADA and subsequent $660 million acquisition of Takeda’s OTC portfolio in Russia and the CIS

Bain Capital Tech Opportunities on:

• its acquisition of finova from Norland Capital and simultaneous acquisition of Iress’s UK mortgage sales and originations software business
• its investment in SumUp as lead investor of a €590 million investment round and its subsequent further investment alongside Sixth Street Growth in a €285 million investment round

Oakley Capital on various transactions, including the:

• reinvestment by Oakley Capital V in Contabo alongside KKR
• acquisition of TechInsights by Oakley Capital IV alongside CVC Growth
• investment in Affinitas Education
• acquisition of ICP Education (now Bright Stars)
• sale of WebPros by Oakley Capital III to CVC and simultaneous $200 million reinvestment by Oakley Capital IV
• acquisition of a majority stake in Globe-Trotter

Vista Equity Partners on various transactions, including the:

• acquisition of Allocate Software from HgCapital, subsequent reinvestment by HgCapital and then sale to RLDatix
• acquisition by its portfolio company Mediaocean of Flashtalking from TA Associates
• £725 million public-to-private of Advanced, subsequent acquisitions by Advanced of Docman, Modern Systems and Kirona and investment by BC Partners
• acquisitions by its portfolio company STATS of Prozone Sports and Perform Group from DAZN to create STATS Perform
• C$4.8 billion public-to-private by its portfolio company Misys of DH Corporation to create Finastra
• acquisition by its portfolio company Granicus of Firmstep
• sale of Sovos Compliance to HgCapital
• equity arrangements in connection with the acquisition of Accelya from Warburg Pincus

ABRY Partners on various transactions, including the:

• investment in Inoapps
• investment in the $350 million capital raise by ERS Insurance
• acquisition of Options Technology from Bregal Sagemount and subsequent acquisition of Fixnetix from DTC Technology Company
• investment in Sermo

GTCR on various transactions, including the:

• acquisition of a majority stake in Worldpay
• €350 million acquisition of TachoSil from Takeda and simultaneous acquisition of Surgical Specialties Corporation from Vivo Capital to create Corza Medical
• acquisition by its portfolio company Resonetics of Medelec
• acquisition of Callcredit from Vitruvian

SJ Berwin LLP

• Associate, 2011–2013

• Trainee Solicitor, 2009–2011